Skip to content

ORTALGO

Active Private limited companyfounded 2001active for 24 yearsAchterheide 1, 3980 Tessenderlo-HamKBO/BCE: BE 0476.306.820 #8 oldest company in Tessenderlo-Ham, Health and social work sector

Lifetime

20 annual accounts with figures on one time axis, 23 filings since 2003
peak of €320,976 in 2025
€320,976▲ 67.3%
lowest -€4,536 in 2020
€125,129▲ 245%
peak of €626,598 in 2024
€544,687▼ 13.1%
€662,977▲ 6.0%
peak of 1.2 FTE in 2018
-not published
Board3 names since 2013
3 directors and 2 others
Documentsfilings and deeds
30-04-2026on the last day
2025micro format
Gross margin from €191,810 to €320,976Result from €36,322 to €125,129Dividend €207,041Equity from €626,598 to €544,687Cash from €39,954 to €146,179

Key points

from the 2025 annual accounts

Equity

€544,687 ▼ 13.1%
626,5982024+125,129Profit-207,041Dividend544,6872025

ORTALGO paid out €207,041 in dividends. That is 165% of the 2025 profit.

Result

€125,129 ▲ 245%
€36,3002024€125,0002025

The result rose in 2025 from €36,322 to €125,129.

Filings

23 annual accounts since 2003
deadline20102020

The last five annual accounts were filed 0 to 10 days before the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 20,148 companies had the same profile as ORTALGO has now. Each dot stands for 51 companies, two years later.

95.0%
were still trading
4.7%
stopped another way
0.2%
went bankrupt
  • Small
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,894 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 20,148 companies, not a prediction for ORTALGO. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Manager
Director
Director

Shares in 1 company,

Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0476306820
Company renamed from DOKTERS SMETS-KOX to ORTALGO (director) and (director) change roles · “Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering…” (deed in Dutch) · Discharge granted to · General meeting of 23-11-2023 · Gazette deed
(manager) and (manager) reappointed General meeting of 24-02-2018 · Gazette deed
(manager) and (manager) reappointed General meeting of 30-03-2012 · Gazette deed
All 38 events

Comparable companies

same main activity, similar in size and age
Company
ORTALGO Tessenderlo-Ham €1.2m €320,976 43.7% -
DR. INE LIBBRECHT Pelt €1.3m €338,293 68.0% -
DR. JACOBS KATHELIJNE - OOGARTS Alken €1.4m €320,493 96.9% -
DOKTER REINOUD CARTUYVELS Heusden-Zolder €1.4m €322,450 81.9% -
DOKTER JAN J. MALCORPS Sint-Truiden €1.3m €351,235 74.3% -
Dokter GEYPEN Oudsbergen €1.3m €346,660 78.2% -
DR. KOEN DE PRAETER, ALGEMENE GENEESKUNDE Evergem €1.2m €318,661 84.1% -

These companies have the same main activity as ORTALGO: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €1.2m and €1.4m, founded between 2000 and 2004.

Official details

Source: KBO
Status
Active since 13-12-2001Normal situation
Activity
Specialist medical practiceNACE 86220and 1 other
Establishment unit
2.231.221.9123980 Tessenderlo-Ham, since 23-03-2006
Financial year end
30 September
Peppol
Reachable since 17-11-2025
Company details

Annual accounts to 30-09-2025

≈ €480,000estimated
€1.2m▼ 3.4%
Filing
Filed on 30-04-2026, on the last day of the filing period
Financials

Insights on ORTALGO

ORTALGO files the micro format. That format states no turnover. The gross margin rose from €94,439 in 2006 to €320,976 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about ORTALGO

What is the company number of ORTALGO?
The company number of ORTALGO is 0476.306.820. The VAT number is the same number with BE in front: BE 0476.306.820.
Where is ORTALGO based?
The registered office is at Achterheide 1, 3980 Tessenderlo-Ham.Company details
What does ORTALGO do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of ORTALGO?
ORTALGO is a private limited company (BV).
When was ORTALGO founded?
ORTALGO was founded on 13-12-2001.
Is ORTALGO still active?
Yes, ORTALGO is an active enterprise in the KBO register.
What is the turnover of ORTALGO?
The turnover in financial year 2025 is about €480,000. This figure is estimated from the gross margin of €320,976 and 31 comparable companies (NACE 86220). It probably lies between €430,000 and €670,000.Financials
Is ORTALGO profitable?
In financial year 2025, ORTALGO made a profit of €125,129.
Where can I find the annual accounts of ORTALGO?
ORTALGO filed 23 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of ORTALGO due?
ORTALGO must file the annual accounts for financial year 2026 by 30-04-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.